In science, quality is everything. Whether you’re uncovering basic insights into the inner workings of biological systems or are on the front lines of developing the next generation of therapeutics or diagnostics, you want your results to stand the test of time. But reliable, reproducible data doesn’t just happen on its own. It takes smart experimental design, skilled execution, and tools you can trust to deliver data that’s both accurate and precise. And it also takes time.
At Ethos Biosciences, we want to give you back some of that time with assay kits, reagents, and services that are high quality, easy to use, and quick to implement. From well thought-out kits designed to minimize preparatory steps and maximize accuracy, to expert support from the scientists that develop and manufacture each kit, to streamlined ordering, our goal is to simplify your path to the high-quality data that builds lasting and high-impact insights.
Ethos Biosciences was formed in 2018 as a subsidiary of Ott Scientific focused on the design, development, and manufacture of high-quality, easy-to-use assay kits, reagents, and services. In November 2018, we acquired the Exocell® diagnostics operation from Glycadia, Inc., as a first step in assembling a world-class product catalog, and look forward to further expanding our offerings.
With the Exocell acquisition, we not only incorporated the widely-cited products, many of which are considered the gold-standard assay in their respective areas, we’ve kept the entire operation. This means that current Exocell customers will continue to receive the same industry-leading products, services, and support that they’ve depended on since the company’s founding in 1988 by Margo Cohen, MD. Ph.D.
A leader in research on diabetes, endocrinology, and metabolism, Margo Cohen founded Exocell in 1988 to develop diabetes-related diagnostic products, and subsequently established Glycadia to develop therapeutic products. Under her leadership, Exocell® quickly became a leader in nephrology diagnostics with 15 patents and over 2000 research citations. Now a part of Ethos Biosciences, Exocell® products continue to serve the top academic, biotech, and pharma research teams across the globe.
Dr. Charles Edelstein joined the Ethos Biosciences Scientific Advisory Board in 2020. As Professor of Medicine - Renal Med Disease/Hypertension at The University of Colorado School of Medicine and practicing clinician and researcher, Dr. Edelstein brings many perspectives to the leadership and scientific rigor of Ethos Biosciences. Dr. Edelstein holds many current professional memberships and is author of "Biomarkers of Kidney Disease, Second Edition" which covers basic, clinical, and latest techniques for biomarkers in kidney disease.
Ott Scientific is a family owned and operated group of specialty chemical manufacturing companies with expertise in monomers, polymers, microspheres, and reagents for the pharmaceutical, medical device, and diagnostic industries.